Kolexia
Kheloufi Farid
Pharmacien
Hôpital Salvator
Marseille, France
38 Activités
530 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Effets secondaires indésirables des médicaments Infections à VIH Anémie Co-infection Syndrome d'hypersensibilité médicamenteuse Hépatite C chronique Constipation Surdose Épilepsies partielles

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
British journal of clinical pharmacology   08 juin 2022
Completeness of pharmacovigilance reporting in general medicine in France..
Sante publique (Vandoeuvre-les-Nancy, France)   28 janvier 2020
Quantitative System Pharmacology (QSP): An Integrative Framework for paradigm change in the treatment of the first-episode schizophrenia.
L'Encephale   14 août 2019
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database.
Journal of the neurological sciences   16 janvier 2019
Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect.
AIDS (London, England)   30 octobre 2018
Comment on "Patient Reporting in the EU: Analysis of EudraVigilance Data".
Drug safety   16 juillet 2018
Interest of take-home naloxone for opioid overdose.
Therapie   07 juillet 2018
Vancomycin-induced eruption in the setting of oral use is not that absurd: a case report and possible explanations
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2018, Toulouse, France   31 mai 2018
Adverse drug reactions related to drug-drug interactions: lower severity level of drug-drug interactions and pharmacodynamic interactions are oversighted
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2018, Toulouse, France   31 mai 2018
Medication errors involving single dose pods before and after an information campaign
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2018, Toulouse, France   31 mai 2018